NCT07133464 CDH1-associated Blepharocheilodontic Syndrome Registry
| NCT ID | NCT07133464 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University |
| Condition | Blepharocheilodontic Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-06-17 |
| Primary Completion | 2040-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-06-17 with a primary completion date of 2040-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the CDH1-associated Blepharocheilodontic Syndrome (BCDS) registry is to better characterize the clinical features of this condition and exploring whether CDH1 variants linked to BCDS may also increase cancer risk.
Eligibility Criteria
Inclusion Criteria: * A documented pathogenic, likely pathogenic or a variant of uncertain significance in the CDH1 gene * Clinical features that are diagnostic for, or suggestive of, BCDS (cleft lip and/or palate, eyelid anomalies, dental abnormalities, webbed toes, imperforate anus, etc) Exclusion Criteria: • Non-English-speaking individuals
Contact & Investigator
Maegan E Roberts, MS
PRINCIPAL INVESTIGATOR
Ohio State University
Frequently Asked Questions
Who can join the NCT07133464 clinical trial?
This trial is open to participants of all sexes, studying Blepharocheilodontic Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07133464 currently recruiting?
Yes, NCT07133464 is actively recruiting participants. Contact the research team at maegan.roberts@osumc.edu for enrollment information.
Where is the NCT07133464 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT07133464 clinical trial?
NCT07133464 is sponsored by Ohio State University. The principal investigator is Maegan E Roberts, MS at Ohio State University. The trial plans to enroll 100 participants.